| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971133 | The Journal of Heart and Lung Transplantation | 2012 | 7 Pages |
Abstract
The important role of CTGF during the development of CAV in heart transplantation was supported by the association of CAV with the recipient CTGF-945 CC/CG genotypes. The CAV patients, who were all receiving everolimus treatment, displayed elevated myocardial CTGF mRNA transcription levels, while everolimus has been observed to reduce serum CTGF protein levels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Malena P. PhD, Athanasios MD, Peter A. MD, Dimitrios MD, PhD,